IHC – HER2/neu is an immunohistochemistry test used to assess HER2 protein overexpression in tumor tissue, especially in breast and gastric cancers. It helps determine eligibility for targeted therapies such as anti-HER2 treatment. Performed on FFPE tissue blocks, it is essential for diagnosis, prognosis, and treatment planning.
Fasting
Not Required
Reporting Time
7–10 Days
Gender
Male/Female
Age Group
All Age Groups
✔ Home collection available ✔ No hidden charges
Need help? Call 1800-123-4567
Kidney / Renal | Heart & Cardiac Health | Liver Test | Comprehensive Diabetes | Comprehensive Thyroid | Child & Adolescent Health | Women's Health | Men's Health | Cancer | Immunity & Allergy Test | Fever & Infection | Pancreas | Vitamins & Nutrition | Sexual Wellness/STDs | Bone & Joint Health | Hormonal | Urine & Stool Test | Infectious Diseases | Covid & Respiratory Health | Obesity & Metabolism | Dental & Oral Health | Eye & Vision Screening | Skin & Hair Health | Senior Citizen Checkups | Mental Health & Wellness | Autoimmune Disorder | Pregnancy & Fertility